Is CDLX or AEYE more profitable?

Audioeye has a net margin of -9.05% compared to Cardlytics' net margin of -46.03%. Audioeye's return on equity of 71.24% beat Cardlytics' return on equity. Company Net Margins Return on Equity Return on Assets Cardlytics -46.03% -956.56% -34.57% Audioeye -9.05% 71.24% 11.35%

Does the media favor CDLX or AEYE?

In the previous week, Cardlytics and Cardlytics both had 1 articles in the media. Audioeye's average media sentiment score of 0.64 beat Cardlytics' score of 0.00 indicating that Audioeye is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cardlytics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Audioeye 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer CDLX or CMCM?

Cardlytics presently has a consensus price target of $10.00, indicating a potential upside of 156.08%. Given Cardlytics' stronger consensus rating and higher possible upside, analysts plainly believe Cardlytics is more favorable than Cheetah Mobile. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cardlytics 2 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Cheetah Mobile 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is CDLX or CMCM more profitable?

Cheetah Mobile has a net margin of -21.14% compared to Cardlytics' net margin of -46.03%. Cheetah Mobile's return on equity of -3.90% beat Cardlytics' return on equity. Company Net Margins Return on Equity Return on Assets Cardlytics -46.03% -956.56% -34.57% Cheetah Mobile -21.14% -3.90% -1.50%

Does the media prefer CDLX or CMCM?

In the previous week, Cardlytics and Cardlytics both had 1 articles in the media. Cheetah Mobile's average media sentiment score of 1.92 beat Cardlytics' score of 0.00 indicating that Cheetah Mobile is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cardlytics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cheetah Mobile 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media prefer CDLX or DH?

In the previous week, Definitive Healthcare had 2 more articles in the media than Cardlytics. MarketBeat recorded 3 mentions for Definitive Healthcare and 1 mentions for Cardlytics. Cardlytics' average media sentiment score of 0.00 beat Definitive Healthcare's score of -0.54 indicating that Cardlytics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cardlytics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Definitive Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Negative

Is IDN or CDLX more profitable?

Intellicheck has a net margin of 9.56% compared to Cardlytics' net margin of -46.03%. Intellicheck's return on equity of 11.26% beat Cardlytics' return on equity. Company Net Margins Return on Equity Return on Assets Intellicheck 9.56% 11.26% 8.92% Cardlytics -46.03% -956.56% -34.57%

Does the media refer more to IDN or CDLX?

In the previous week, Intellicheck had 3 more articles in the media than Cardlytics. MarketBeat recorded 4 mentions for Intellicheck and 1 mentions for Cardlytics. Cardlytics' average media sentiment score of 0.00 beat Intellicheck's score of -0.24 indicating that Cardlytics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Intellicheck 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Cardlytics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate CDLX or BNAI?

Cardlytics presently has a consensus price target of $10.00, suggesting a potential upside of 156.08%. Given Cardlytics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Cardlytics is more favorable than Brand Engagement Network. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cardlytics 2 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Brand Engagement Network 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Cardlytics (CDLX) Competitors

$3.90 -0.01 (-0.13%)

As of 12:54 PM Eastern

Compare

CDLX vs. AEYE, CMCM, DH, IDN, and BNAI

Should you buy Cardlytics stock or one of its competitors? MarketBeat compares Cardlytics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cardlytics include Audioeye (AEYE), Cheetah Mobile (CMCM), Definitive Healthcare (DH), Intellicheck (IDN), and Brand Engagement Network (BNAI). These companies are all part of the "computer software" industry.

How does Cardlytics compare to Audioeye?

Cardlytics (NASDAQ:CDLX) and Audioeye (NASDAQ:AEYE) are both small-cap computer software companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, institutional ownership, media sentiment, risk and dividends.

Audioeye has lower revenue, but higher earnings than Cardlytics. Audioeye is trading at a lower price-to-earnings ratio than Cardlytics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardlytics	$233.27M	0.10	-$103.49M	-$17.70	N/A
Audioeye	$40.31M	1.97	-$3.08M	-$0.29	N/A

Cardlytics has a beta of 0.61, indicating that its stock price is 39% less volatile than the broader market. Comparatively, Audioeye has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market.

Cardlytics presently has a consensus target price of $10.00, indicating a potential upside of 156.08%. Audioeye has a consensus target price of $14.63, indicating a potential upside of 130.28%. Given Cardlytics' higher probable upside, analysts plainly believe Cardlytics is more favorable than Audioeye.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cardlytics	2 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Audioeye	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Audioeye has a net margin of -9.05% compared to Cardlytics' net margin of -46.03%. Audioeye's return on equity of 71.24% beat Cardlytics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cardlytics	-46.03%	-956.56%	-34.57%
Audioeye	-9.05%	71.24%	11.35%

In the previous week, Cardlytics and Cardlytics both had 1 articles in the media. Audioeye's average media sentiment score of 0.64 beat Cardlytics' score of 0.00 indicating that Audioeye is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cardlytics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Audioeye	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

68.1% of Cardlytics shares are owned by institutional investors. Comparatively, 51.1% of Audioeye shares are owned by institutional investors. 5.9% of Cardlytics shares are owned by company insiders. Comparatively, 25.9% of Audioeye shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Audioeye beats Cardlytics on 11 of the 15 factors compared between the two stocks.

How does Cardlytics compare to Cheetah Mobile?

Cardlytics (NASDAQ:CDLX) and Cheetah Mobile (NYSE:CMCM) are both small-cap computer software companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings, media sentiment and analyst recommendations.

Cardlytics presently has a consensus price target of $10.00, indicating a potential upside of 156.08%. Given Cardlytics' stronger consensus rating and higher possible upside, analysts plainly believe Cardlytics is more favorable than Cheetah Mobile.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cardlytics	2 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Cheetah Mobile	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Cheetah Mobile has lower revenue, but higher earnings than Cardlytics. Cheetah Mobile is trading at a lower price-to-earnings ratio than Cardlytics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardlytics	$233.27M	0.10	-$103.49M	-$17.70	N/A
Cheetah Mobile	$164.51M	0.55	-$36.85M	-$1.17	N/A

Cardlytics has a beta of 0.61, suggesting that its share price is 39% less volatile than the broader market. Comparatively, Cheetah Mobile has a beta of 1.82, suggesting that its share price is 82% more volatile than the broader market.

68.1% of Cardlytics shares are owned by institutional investors. Comparatively, 0.4% of Cheetah Mobile shares are owned by institutional investors. 5.9% of Cardlytics shares are owned by insiders. Comparatively, 17.1% of Cheetah Mobile shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Cheetah Mobile has a net margin of -21.14% compared to Cardlytics' net margin of -46.03%. Cheetah Mobile's return on equity of -3.90% beat Cardlytics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cardlytics	-46.03%	-956.56%	-34.57%
Cheetah Mobile	-21.14%	-3.90%	-1.50%

In the previous week, Cardlytics and Cardlytics both had 1 articles in the media. Cheetah Mobile's average media sentiment score of 1.92 beat Cardlytics' score of 0.00 indicating that Cheetah Mobile is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cardlytics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cheetah Mobile	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Cheetah Mobile beats Cardlytics on 9 of the 14 factors compared between the two stocks.

How does Cardlytics compare to Definitive Healthcare?

Cardlytics (NASDAQ:CDLX) and Definitive Healthcare (NASDAQ:DH) are both small-cap computer software companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

Cardlytics has higher earnings, but lower revenue than Definitive Healthcare. Definitive Healthcare is trading at a lower price-to-earnings ratio than Cardlytics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardlytics	$233.27M	0.10	-$103.49M	-$17.70	N/A
Definitive Healthcare	$241.52M	0.31	-$138.93M	-$1.62	N/A

In the previous week, Definitive Healthcare had 2 more articles in the media than Cardlytics. MarketBeat recorded 3 mentions for Definitive Healthcare and 1 mentions for Cardlytics. Cardlytics' average media sentiment score of 0.00 beat Definitive Healthcare's score of -0.54 indicating that Cardlytics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cardlytics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Definitive Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Negative

Cardlytics has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.33, meaning that its stock price is 33% more volatile than the broader market.

Cardlytics has a net margin of -46.03% compared to Definitive Healthcare's net margin of -76.04%. Definitive Healthcare's return on equity of 4.04% beat Cardlytics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cardlytics	-46.03%	-956.56%	-34.57%
Definitive Healthcare	-76.04%	4.04%	1.99%

68.1% of Cardlytics shares are owned by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are owned by institutional investors. 5.9% of Cardlytics shares are owned by company insiders. Comparatively, 17.1% of Definitive Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Cardlytics currently has a consensus target price of $10.00, indicating a potential upside of 156.08%. Definitive Healthcare has a consensus target price of $2.47, indicating a potential upside of 249.57%. Given Definitive Healthcare's stronger consensus rating and higher probable upside, analysts clearly believe Definitive Healthcare is more favorable than Cardlytics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cardlytics	2 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Definitive Healthcare	4 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	1.89

Summary

Definitive Healthcare beats Cardlytics on 13 of the 17 factors compared between the two stocks.

How does Cardlytics compare to Intellicheck?

Intellicheck (NASDAQ:IDN) and Cardlytics (NASDAQ:CDLX) are both small-cap computer software companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, media sentiment, profitability, valuation, earnings, risk and institutional ownership.

In the previous week, Intellicheck had 3 more articles in the media than Cardlytics. MarketBeat recorded 4 mentions for Intellicheck and 1 mentions for Cardlytics. Cardlytics' average media sentiment score of 0.00 beat Intellicheck's score of -0.24 indicating that Cardlytics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Intellicheck	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cardlytics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Intellicheck has a net margin of 9.56% compared to Cardlytics' net margin of -46.03%. Intellicheck's return on equity of 11.26% beat Cardlytics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intellicheck	9.56%	11.26%	8.92%
Cardlytics	-46.03%	-956.56%	-34.57%

Intellicheck presently has a consensus target price of $7.38, suggesting a potential upside of 91.81%. Cardlytics has a consensus target price of $10.00, suggesting a potential upside of 156.08%. Given Cardlytics' higher probable upside, analysts clearly believe Cardlytics is more favorable than Intellicheck.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intellicheck	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Cardlytics	2 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Intellicheck has higher earnings, but lower revenue than Cardlytics. Cardlytics is trading at a lower price-to-earnings ratio than Intellicheck, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intellicheck	$22.67M	3.43	$1.27M	$0.11	34.95
Cardlytics	$233.27M	0.10	-$103.49M	-$17.70	N/A

Intellicheck has a beta of 0.8, meaning that its share price is 20% less volatile than the broader market. Comparatively, Cardlytics has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market.

42.8% of Intellicheck shares are held by institutional investors. Comparatively, 68.1% of Cardlytics shares are held by institutional investors. 7.8% of Intellicheck shares are held by insiders. Comparatively, 5.9% of Cardlytics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Intellicheck beats Cardlytics on 12 of the 16 factors compared between the two stocks.

How does Cardlytics compare to Brand Engagement Network?

Cardlytics (NASDAQ:CDLX) and Brand Engagement Network (NASDAQ:BNAI) are both small-cap business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, media sentiment, earnings, analyst recommendations, risk, institutional ownership and dividends.

Cardlytics has a net margin of -46.03% compared to Brand Engagement Network's net margin of -2,189.33%. Brand Engagement Network's return on equity of -235.73% beat Cardlytics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cardlytics	-46.03%	-956.56%	-34.57%
Brand Engagement Network	-2,189.33%	-235.73%	-72.24%

68.1% of Cardlytics shares are held by institutional investors. Comparatively, 15.8% of Brand Engagement Network shares are held by institutional investors. 5.9% of Cardlytics shares are held by insiders. Comparatively, 25.6% of Brand Engagement Network shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Cardlytics has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market. Comparatively, Brand Engagement Network has a beta of 0.38, meaning that its share price is 62% less volatile than the broader market.

Cardlytics presently has a consensus price target of $10.00, suggesting a potential upside of 156.08%. Given Cardlytics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Cardlytics is more favorable than Brand Engagement Network.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cardlytics	2 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Brand Engagement Network	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Brand Engagement Network has lower revenue, but higher earnings than Cardlytics. Brand Engagement Network is trading at a lower price-to-earnings ratio than Cardlytics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardlytics	$233.27M	0.10	-$103.49M	-$17.70	N/A
Brand Engagement Network	$280K	247.71	-$8.62M	-$1.81	N/A

In the previous week, Cardlytics had 1 more articles in the media than Brand Engagement Network. MarketBeat recorded 1 mentions for Cardlytics and 0 mentions for Brand Engagement Network. Cardlytics' average media sentiment score of 0.00 equaled Brand Engagement Network'saverage media sentiment score.

Company	Overall Sentiment
Cardlytics	Neutral
Brand Engagement Network	Neutral

Summary

Cardlytics beats Brand Engagement Network on 9 of the 14 factors compared between the two stocks.

Get Cardlytics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CDLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CDLX vs. The Competition

Export

Metric	Cardlytics	Technology Services Industry	Business Sector	NASDAQ Exchange
Market Cap	$22.68M	$3.83B	$6.87B	$12.42B
Dividend Yield	N/A	2.15%	3.04%	9.39%
P/E Ratio	-0.22	34.98	28.89	24.17
Price / Sales	0.10	43.97	346.47	92.83
Price / Cash	N/A	34.44	22.57	47.25
Price / Book	-3.25	4.06	5.69	6.23
Net Income	-$103.49M	$31.76M	$204.05M	$331.42M
7 Day Performance	-7.46%	-2.52%	-1.43%	-1.22%
1 Month Performance	-24.90%	-8.00%	-2.91%	-1.36%
1 Year Performance	-80.76%	-0.55%	10.33%	18.43%

Cardlytics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CDLX Cardlytics	2.3047 of 5 stars	$3.91 -0.1%	$10.00 +156.1%	-76.7%	$22.68M	$233.27M	N/A	500	News Coverage
AEYE Audioeye	3.82 of 5 stars	$7.46 +1.4%	$14.63 +96.2%	-46.2%	$93.11M	$40.31M	N/A	110
CMCM Cheetah Mobile	1.2702 of 5 stars	$3.05 -0.8%	N/A	-42.2%	$92.32M	$164.51M	N/A	850	Positive News
DH Definitive Healthcare	2.9467 of 5 stars	$0.84 +4.0%	$2.47 +196.0%	-81.2%	$86.63M	$241.52M	N/A	970	Analyst Downgrade
IDN Intellicheck	3.7362 of 5 stars	$4.19 +2.2%	$7.38 +76.0%	-26.4%	$84.87M	$22.67M	38.10	50

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CDLX) was last updated on 7/21/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cardlytics (CDLX) Competitors

CDLX vs. AEYE, CMCM, DH, IDN, and BNAI

How does Cardlytics compare to Audioeye?

Summary

How does Cardlytics compare to Cheetah Mobile?

Summary

How does Cardlytics compare to Definitive Healthcare?

Summary

How does Cardlytics compare to Intellicheck?

Summary

How does Cardlytics compare to Brand Engagement Network?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CDLX vs. The Competition

Cardlytics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cardlytics (CDLX) Competitors

CDLX vs. AEYE, CMCM, DH, IDN, and BNAI

How does Cardlytics compare to Audioeye?

Which has better valuation & earnings, CDLX or AEYE?

Which has more risk & volatility, CDLX or AEYE?

Do analysts recommend CDLX or AEYE?

Is CDLX or AEYE more profitable?

Does the media favor CDLX or AEYE?

Do institutionals and insiders believe in CDLX or AEYE?

Summary

How does Cardlytics compare to Cheetah Mobile?

Do analysts prefer CDLX or CMCM?

Which has better earnings & valuation, CDLX or CMCM?

Which has more risk & volatility, CDLX or CMCM?

Do institutionals & insiders believe in CDLX or CMCM?

Is CDLX or CMCM more profitable?

Does the media prefer CDLX or CMCM?

Summary

How does Cardlytics compare to Definitive Healthcare?

Which has higher valuation & earnings, CDLX or DH?

Does the media prefer CDLX or DH?

Which has more volatility & risk, CDLX or DH?

Is CDLX or DH more profitable?

Do insiders & institutionals believe in CDLX or DH?

Do analysts rate CDLX or DH?

Summary

How does Cardlytics compare to Intellicheck?

Does the media refer more to IDN or CDLX?

Is IDN or CDLX more profitable?

Do analysts rate IDN or CDLX?

Which has stronger valuation & earnings, IDN or CDLX?

Which has more risk & volatility, IDN or CDLX?

Do institutionals and insiders hold more shares of IDN or CDLX?

Summary

How does Cardlytics compare to Brand Engagement Network?

Is CDLX or BNAI more profitable?

Do insiders & institutionals hold more shares of CDLX or BNAI?

Which has more volatility & risk, CDLX or BNAI?

Do analysts rate CDLX or BNAI?

Which has preferable valuation & earnings, CDLX or BNAI?

Does the media prefer CDLX or BNAI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CDLX vs. The Competition

Cardlytics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools